SCAI 2026 Treatment and Management of Complex Peripheral Arterial Disease-Treatment of Femoropopliteal Disease: Bare, Covered, or Drug, Dr. Pham Ryan

Treatment of Femoropopliteal Disease: Bare, Covered, or Drug, Dr. Pham Ryan

Video Transcription

Video Summary

The speaker reviewed treatment options for femoropopliteal disease, tracing the evolution from plain balloon angioplasty to bare metal stents, covered stents, drug-eluting stents, and drug-coated balloons. He highlighted the strengths and limitations of each: recoil and restenosis with early angioplasty, fracture and restenosis with bare metal stents, thrombosis and edge stenosis with covered stents, and safety/cost concerns with drug therapies. He cited key trials showing improved patency with newer devices. Overall, a 2025 consensus favors drug-coated balloons for many simpler lesions, while drug-eluting stents may be better for longer, calcified, or more complex disease.

Asset Caption

closed captions are computer-generated

Keywords

femoropopliteal disease

drug-coated balloons

drug-eluting stents

bare metal stents

restenosis